FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088202275> ?p ?o ?g. }

• W2088202275 endingPage "87" @default.
• W2088202275 startingPage "79" @default.
• W2088202275 abstract "Although prolactin (PRL) has been long suspected to be involved in the progression of human breast cancer, the failure of clinical improvement by treatment with dopamine agonists, which lower circulating levels of PRL, rapidly reduced the interest of oncologists concerning a potential role of this pituitary hormone in the development of breast cancer. Within the last few years, however, several studies reported first, that PRL is also synthesized in the mammary gland, and second that it exerts its proliferative action in an autocrine/paracrine manner. These observations have led to a reconsideration of the role of PRL as an active participant in breast cancer and are an impetus to search for alternative strategies aimed at inhibiting the proliferative effects of PRL on tumor mammary cells. In this report, we discuss the three possible levels that can be targeted for this purpose: the mammary synthesis of PRL, the interaction of the hormone with its receptor at the surface of mammary cells, and the intracellular signaling cascades triggered by the activated receptor. For each of these steps, we discuss the molecular event(s) that can be targeted, our understanding of the mechanisms involving these putative targets as well as the tools currently available for their inhibition. Besides its proliferative effect, PRL is also involved in the control of angiogenesis through one of its cleaved fragments, named PRL 16K, which has been shown to inhibit the angiogenic process. In view of this biological activity, we discuss first the cleavage of PRL with respect to the human mammary gland and, second, the hypothesis speculating that a balance between the proliferative effect of intact PRL and the anti-angiogenic activity of its 16K-like fragments might be physiologically relevant in the evolution of mammary tumors. If true, our hypothesis would suggest that the enzymatic cleavage of PRL could represent a new molecular target in the search for alternative strategies in the treatment of breast cancer." @default.
• W2088202275 created "2016-06-24" @default.
• W2088202275 creator A5007870509 @default.
• W2088202275 creator A5034675512 @default.
• W2088202275 creator A5041012326 @default.
• W2088202275 creator A5054995632 @default.
• W2088202275 creator A5075896256 @default.
• W2088202275 date "1999-05-01" @default.
• W2088202275 modified "2023-09-26" @default.
• W2088202275 title "Should prolactin be reconsidered as a therapeutic target in human breast cancer?" @default.
• W2088202275 cites W124018961 @default.
• W2088202275 cites W1268960040 @default.
• W2088202275 cites W1497816013 @default.
• W2088202275 cites W1559736216 @default.
• W2088202275 cites W1566261029 @default.
• W2088202275 cites W1578549298 @default.
• W2088202275 cites W1580463729 @default.
• W2088202275 cites W1593314637 @default.
• W2088202275 cites W1837651204 @default.
• W2088202275 cites W1902189520 @default.
• W2088202275 cites W1964961772 @default.
• W2088202275 cites W1969890794 @default.
• W2088202275 cites W1973096120 @default.
• W2088202275 cites W1973396607 @default.
• W2088202275 cites W1973596639 @default.
• W2088202275 cites W1974656027 @default.
• W2088202275 cites W1975362875 @default.
• W2088202275 cites W1976881439 @default.
• W2088202275 cites W1985804036 @default.
• W2088202275 cites W1987030721 @default.
• W2088202275 cites W1988812517 @default.
• W2088202275 cites W1992023050 @default.
• W2088202275 cites W1994231910 @default.
• W2088202275 cites W1997785224 @default.
• W2088202275 cites W1998002970 @default.
• W2088202275 cites W2000111014 @default.
• W2088202275 cites W2013733324 @default.
• W2088202275 cites W2017520393 @default.
• W2088202275 cites W2017885815 @default.
• W2088202275 cites W2023807517 @default.
• W2088202275 cites W2024953733 @default.
• W2088202275 cites W2025091441 @default.
• W2088202275 cites W2025864476 @default.
• W2088202275 cites W2026329080 @default.
• W2088202275 cites W2027721018 @default.
• W2088202275 cites W2032516148 @default.
• W2088202275 cites W2035936653 @default.
• W2088202275 cites W2038910312 @default.
• W2088202275 cites W2043219540 @default.
• W2088202275 cites W2045026523 @default.
• W2088202275 cites W2058706806 @default.
• W2088202275 cites W2062447372 @default.
• W2088202275 cites W2062860025 @default.
• W2088202275 cites W2083802827 @default.
• W2088202275 cites W2094941715 @default.
• W2088202275 cites W2102587794 @default.
• W2088202275 cites W2127048642 @default.
• W2088202275 cites W2147028876 @default.
• W2088202275 cites W2147666122 @default.
• W2088202275 cites W2289890847 @default.
• W2088202275 cites W2400107736 @default.
• W2088202275 cites W2408721985 @default.
• W2088202275 cites W3125046965 @default.
• W2088202275 cites W4232735079 @default.
• W2088202275 cites W4232849990 @default.
• W2088202275 cites W4234262644 @default.
• W2088202275 cites W4235810023 @default.
• W2088202275 cites W4236155346 @default.
• W2088202275 cites W4239142818 @default.
• W2088202275 cites W4240919346 @default.
• W2088202275 cites W4243973028 @default.
• W2088202275 cites W4246509570 @default.
• W2088202275 cites W4248515563 @default.
• W2088202275 cites W4256524855 @default.
• W2088202275 doi "https://doi.org/10.1016/s0303-7207(99)00023-4" @default.
• W2088202275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10411322" @default.
• W2088202275 hasPublicationYear "1999" @default.
• W2088202275 type Work @default.
• W2088202275 sameAs 2088202275 @default.
• W2088202275 citedByCount "60" @default.
• W2088202275 countsByYear W20882022752012 @default.
• W2088202275 countsByYear W20882022752013 @default.
• W2088202275 countsByYear W20882022752014 @default.
• W2088202275 countsByYear W20882022752016 @default.
• W2088202275 countsByYear W20882022752017 @default.
• W2088202275 countsByYear W20882022752019 @default.
• W2088202275 countsByYear W20882022752020 @default.
• W2088202275 crossrefType "journal-article" @default.
• W2088202275 hasAuthorship W2088202275A5007870509 @default.
• W2088202275 hasAuthorship W2088202275A5034675512 @default.
• W2088202275 hasAuthorship W2088202275A5041012326 @default.
• W2088202275 hasAuthorship W2088202275A5054995632 @default.
• W2088202275 hasAuthorship W2088202275A5075896256 @default.
• W2088202275 hasConcept C121608353 @default.
• W2088202275 hasConcept C126322002 @default.
• W2088202275 hasConcept C128240485 @default.
• W2088202275 hasConcept C134018914 @default.
• W2088202275 hasConcept C170493617 @default.

• next